KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Shares Repurchased (2023 - 2025)

Zimmer Biomet Holdings has reported Shares Repurchased over the past 10 years, most recently at $250.0 million for Q4 2025.

  • Quarterly results put Shares Repurchased at $250.0 million for Q4 2025, up 246.26% from a year ago — trailing twelve months through Dec 2025 was $487.0 million (down 43.89% YoY), and the annual figure for FY2025 was $487.0 million, down 43.89%.
  • Shares Repurchased for Q4 2025 was $250.0 million at Zimmer Biomet Holdings, up from $7.2 million in the prior quarter.
  • Over the last five years, Shares Repurchased for ZBH hit a ceiling of $596.3 million in Q3 2024 and a floor of $7.2 million in Q2 2025.
  • Median Shares Repurchased over the past 3 years was $171.7 million (2024), compared with a mean of $204.7 million.
  • Biggest five-year swings in Shares Repurchased: skyrocketed 500.7% in 2024 and later plummeted 91.62% in 2025.
  • Zimmer Biomet Holdings' Shares Repurchased stood at $410.3 million in 2023, then plummeted by 82.4% to $72.2 million in 2024, then skyrocketed by 246.26% to $250.0 million in 2025.
  • The last three reported values for Shares Repurchased were $250.0 million (Q4 2025), $7.2 million (Q2 2025), and $229.8 million (Q1 2025) per Business Quant data.